Colorado is currently home to 1779 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Denver, Aurora, Colorado Springs and Englewood. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
The Diagnostic Experience of Male Rett Syndrome
NCT06346106
Recruiting
The Diagnostic Experience of Male Rett Syndrome collects information on the lived experiences of parents or caregivers to boys with Rett Syndrome. Key information examined includes the process of getting a male Rett syndrome diagnosis, your son's systems of care, and your priorities for his health needs. Enrolled participants will complete an online survey with questions about having a son with Rett Syndrome. The Diagnostic Experience of Male Rett Syndrome study is available to parents or careg... Read More
Gender:
MALE
Ages:
Between 0 years and 100 years
Trial Updated:
03/28/2024
Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado
Conditions: Rett Syndrome, RTT
Register for Updates
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
NCT04968548
Recruiting
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
03/28/2024
Locations: Centura Health, Lakewood, Colorado
Conditions: Lung Cancer
Register for Updates
Examining the Effects of Morning and Evening Exercise on Glucose Regulation in Adults With Prediabetes
NCT06292000
Recruiting
Purpose of the Study: This study is to learn more about how exercising at different times of the day (morning versus evening) affects metabolism of glucose in the body, sleep, activity outside of exercise, and other factors. Procedures: * 2 screening visits to make sure you are eligible to be in the study. This will include a fasting blood draw and heart tracing (EKG). * If you are eligible, you will complete both exercise conditions in a random order. All participants in the study will comple... Read More
Gender:
ALL
Ages:
Between 20 years and 40 years
Trial Updated:
03/27/2024
Locations: University of Colorado, Aurora, Colorado
Conditions: PreDiabetes, Obesity, Inactivity/Low Levels of Exercise
Register for Updates
A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision
NCT06291090
Recruiting
The investigators implemented a multi-site hospital-based opioid use disorder (OUD) treatment intervention across 12 hospitals in Colorado to address an OUD treatment gap among hospitalized adults with OUD.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
03/27/2024
Locations: University of Colorado Anschutz Medicl Campus, Aurora, Colorado
Conditions: Opioid Use Disorder
Register for Updates
Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
NCT06182358
Recruiting
To compare the efficacy of XDEMVY ophthalmic drop to its vehicle control for the treatment of Demodex blepharitis and its impact on the soft contact lens wearing experience.
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
03/22/2024
Locations: Vision Institute, Colorado Springs, Colorado
Conditions: Demodex Blepharitis
Register for Updates
Pulse Rate and Breathing Rate Accuracy
NCT06298981
Recruiting
The purpose of this study is to conduct a Breathing Rate and Pulse Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference devices, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) and a standard ECG (GE Datex-Ohmeda) derived heart rate reference. This will be done by manually scoring the collected waveform for data analysis.
Gender:
ALL
Ages:
Between 18 years and 81 years
Trial Updated:
03/21/2024
Locations: Element Materials Technology, Louisville, Colorado
Conditions: Pulse Rate and Breathing Rate
Register for Updates
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
NCT05500222
Recruiting
This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepatitis (NASH) cirrhosis by measuring the time to experiencing a Composite Clinical Outcome event.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/21/2024
Locations: South Denver Gastroenterology, Englewood, Colorado
Conditions: NASH, Cirrhosis, Liver
Register for Updates
SportsPro: Post-Market Clinical Follow Up Study
NCT06320925
Recruiting
Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/20/2024
Locations: Steadman Hawkins Clinic Denver, Englewood, Colorado
Conditions: Shoulder Injuries, Knee Injuries, Hip Injuries
Register for Updates
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
NCT05361707
Recruiting
This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants with ASD.
Gender:
ALL
Ages:
Between 2 years and 65 years
Trial Updated:
03/19/2024
Locations: Vanda Investigational Site, Boulder, Colorado
Conditions: Autism Spectrum Disorder, Sleep Disorder, Neurological Disorder, Sleep Disturbance
Register for Updates
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
NCT04844359
Recruiting
Up to 135 patients with hypersensitivity pneumonitis will be enrolled at 7 clinical centers across the United States. Patients will be followed for 24 months to determine if biomarkers in the blood can predict disease progression.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
03/19/2024
Locations: National Jewish Health, Denver, Colorado
Conditions: Hypersensitivity Pneumonitis
Register for Updates
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
NCT05230810
Recruiting
Phase IB/II clinical trial of Alpelisb and Tucatinib in patients with PIK3CA-Mutant HER2-positive metastatic breast cancer.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/18/2024
Locations: University of Colorado Cancer Center, Aurora, Colorado
Conditions: HER2-positive Metastatic Breast Cancer
Register for Updates
ENRICH Nurse-Family Partnership Study
NCT05798039
Recruiting
The overarching goal of the proposed study is to develop and test an enrichment to Nurse-Family Partnership (NFP) using an existing, evidence-based program to improve clients' and their children's cardiovascular health from early pregnancy to 24 months postpartum. With support from NFP supervisors and nurses, the investigators will develop new NFP materials promoting healthy diet, activity, sleep, and smoking behaviors, along with optimal weight, glycemia, lipid, and blood pressure profiles. The... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
03/15/2024
Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado
Conditions: Blood Pressure, Body Composition, Blood Sugar, Body Weight, Diet Habit, Physical Inactivity
Register for Updates